THE CORPORATION IS ORGANIZED AND SHALL OPERATE FOR THE PURPOSE OF CONDUCTING SCIENTIFIC RESEARCH FOR THE TREATMENT OF MALIGNANCIES AND DISEASES INCLUDING COVID-19, UTILIZING STEM CELL BASED APPROACHES IN ORDER TO IMPROVE THE QUALITY OF LIFE AND THE MAKING OF DISTRIBUTIONS TO ORGANIZATIONS THAT QUALIFY AS EXEMPT ORGANIZATIONS UNDER SECTION 501(C)(3), 2055(A) AND 170 (C)(2) OF THE INTERNAL REVENUE CODE.
Fill out your profile to be more discoverable and compelling to Millie donors.